SCHEMBL6300807

SCHEMBL6300807

COc1ccc(NC(=O)c2ccccc2-c2cccc(OC)c2)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.80
POLB P06746 1/20 0.80
KDM4E B2RXH2 3/20 0.74
NPC1 O15118 3/20 0.60
RAB9A P51151 2/20 0.60
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
ALDH1A1 P00352 4/20 0.58
MAPT P10636 2/20 0.58
LMNA P02545 2/20 0.58
TSHR P16473 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
MAPK1 P28482 1/20 0.58
METAP2 P50579 1/20 0.58
PLG P00747 1/20 0.57
PLAU P00749 1/20 0.57
PLAT P00750 1/20 0.57
CYP3A4 P08684 1/20 0.57
PNLIP P16233 1/20 0.56
CASP3 P42574 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6294665 0.91 GAA (0.73) GAAPOLBKDM4ENPC1RAB9A
SCHEMBL6295717 0.91 GAA (0.70) GAAPOLBKDM4ENPC1RAB9A
SCHEMBL6294912 0.89 GAA (0.74) GAAPOLBKDM4ENPC1RAB9A
SCHEMBL6295710 0.89 GAA (0.74) GAAPOLBKDM4ENPC1RAB9A
SCHEMBL31393767 0.83 GAA (0.89) GAAPOLBKDM4ENPC1RAB9A
SCHEMBL977594 0.83 GAA (0.65) GAAPOLBKDM4ENPC1RAB9A
SCHEMBL8715012 0.83 GAA (0.89) GAAPOLBKDM4ENPC1RAB9A
SCHEMBL7132902 0.83 GAA (0.87) GAAPOLBKDM4ENPC1RAB9A
SCHEMBL1515816 0.82 GAA (0.62) GAAPOLBKDM4ENPC1RAB9A
SCHEMBL9157129 0.81 GAA (0.62) GAAPOLBKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897316-B2 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-05-24 US disclosed
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents TP53, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHUK GAA 211/4885POLB 1876/4885KDM4E 1042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.